CSNK2B Polyclonal Antibody

CSNK2B Polyclonal Antibody

The CSNK2B Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of CSNK2B protein expression in various biological samples. This antibody has been meticulously developed using advanced techniques to ensure exceptional sensitivity and specificity.

CSNK2B, also known as Casein Kinase 2 Beta, is a regulatory subunit of the Casein Kinase 2 (CK2) enzyme. CK2 is a highly conserved serine/threonine protein kinase that plays a crucial role in various cellular processes, including cell growth, proliferation, and differentiation. CSNK2B acts as a stabilizing subunit of CK2, enhancing its catalytic activity and substrate specificity.

The CSNK2B Polyclonal Antibody exhibits outstanding performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It has been rigorously validated to ensure accurate and reproducible results. This antibody demonstrates minimal cross-reactivity with other proteins, ensuring specific detection of CSNK2B.

With its high affinity and sensitivity, the CSNK2B Polyclonal Antibody enables precise quantification of CSNK2B protein levels in different experimental settings. It is suitable for use in both basic research and clinical studies, providing valuable insights into the role of CSNK2B in various physiological and pathological processes.

The CSNK2B Polyclonal Antibody is supplied as a liquid formulation, allowing for easy handling and storage. It is provided in various sizes to accommodate different experimental needs. Each batch of antibody undergoes stringent quality control measures to ensure consistent performance and reliability.

In summary, the CSNK2B Polyclonal Antibody is a highly specific and sensitive tool for the detection and analysis of CSNK2B protein expression. Its exceptional performance and reliability make it an invaluable asset for researchers and clinicians alike, facilitating a deeper understanding of the biological functions and potential therapeutic implications of CSNK2B.